Alira Health and GDMH together to boost Life Sciences innovation

The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.

Alira Health, a global advisory and clinical research firm with the mission to humanize healthcare and life sciences, announces a new collaboration agreement signed with GDMH – Gemelli Digital Medicine & Health, part of Fondazione Policlinico Agostino Gemelli IRCCS (FPG) and prime provider of turn-key solutions in digital medicine and health in Italy. The goal of this partnership is to develop innovative solutions in the fields of Digital Health, Real-World Evidence (RWE) and Market Access in the best interest of research and patients, while ensuring the highest standards of data quality and protection.

We are thrilled to kick start this partnership with GDMH to accelerate the adoption of patient-centered technologies in our quest to humanize healthcare. We are joining forces with GDMH to build, in partnership with patients, digital health solutions that enable a full spectrum of use cases, including Decentralized Clinical Trials, Patient Support Programs, and DTx for pharma, MedTech, providers, and the payer community. Together GDMH and Alira Health bring a wealth of knowledge in clinical development, health tech, data science, market access, commercial strategy, and RWE.”
Piergiulio Lauriano Chief Strategy Officer at Alira Health
We at GDMH look forward to this collaboration in order to bring our digital solutions closer to the clinical research domain in a pragmatic and efficient way. It will help deepen each party's capabilities and bring lessons and solutions to GDMH, the healthcare and Pharma industries, as well as to the medical community and patients, and possibly to other industry sectors.”
Alfredo Cesario Chief Executive Officer at GDMH
Alira Health and GDMH will collaborate together in the fields of Digital Health, RWE and Market Access to co-develop innovative solutions in the best interests of research and patients. Thanks to this partnership, we will be able to merge our know-how, network, and capabilities, to explore the use of innovative digital health solutions and enable a full spectrum of use cases of joint value for both GDMH and Alira Health.”
Jean-François Ricci Chief Access Officer at Alira Health
About Alira Health

Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.

Learn more: www.alirahealth.com

About GDMH – Gemelli Digital Medicine & Health

Gemelli Digital Medicine & Health (GDMH), a company fully owned by Fondazione Policlinico Gemelli, is a prime integrator and provider of turn-key solutions in Digital Medicine and Health. First movers in the market with the profile of a large general hospital spin off we co-create together with the best players in the Digital Medicine scenario, deploy and manage advanced digital medical solutions worldwide with complete ethical, technical, and legal credentials.

Learn more: www.gdmh.it

Related news

Publications November 22, 2022
External Control Arms: The Way to Go?
The growing implementation of Single Arm Trials (SATs) with External Control Arms (ECAs) has been the subject of heated debate across Europe.
Clinical Trials Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.